Thrivent Financial for Lutherans’s ADMA Biologics ADMA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.43M Sell
158,856
-3,631,662
-96% -$57.3M ﹤0.01% 1672
2025
Q4
$69.1M Sell
3,790,518
-351,322
-8% -$5.92M 0.12% 194
2025
Q3
$60.7M Buy
4,141,840
+826,415
+25% +$14.2M 0.12% 202
2025
Q2
$60.4M Buy
3,315,425
+1,453,924
+78% +$29.6M 0.13% 189
2025
Q1
$36.9M Buy
1,861,501
+1,673,881
+892% +$28.9M 0.08% 297
2024
Q4
$3.22M Sell
187,620
-2,585
-1% -$48.6K 0.01% 1133
2024
Q3
$3.8M Buy
+190,205
New +$2.96M 0.01% 1056
2021
Q2
Sell
-37,525
Closed -$66K 2451
2021
Q1
$66K Sell
37,525
-156,225
-81% -$358K ﹤0.01% 2512
2020
Q4
$378K Hold
193,750
﹤0.01% 2222
2020
Q3
$463K Sell
193,750
-1,616
-0.8% -$4.43K ﹤0.01% 2006
2020
Q2
$573K Hold
195,366
﹤0.01% 1839
2020
Q1
$563K Buy
+195,366
New +$675K ﹤0.01% 1654

Other funds holding ADMA